Bulletin 01-21-01 Administration of SARS-CoV-2 Janssen Biotech Vaccine

The purpose of this bulletin is to inform Medical Assistance (MA) providers that the Department of Human Services (Department) added Current Procedural Terminology (CPT) code 0031A to the MA Program Fee Schedule for the administration of the novel coronavirus (SARS-CoV-2) vaccine manufactured by Janssen Biotech, Inc. in response to the coronavirus disease 2019 (COVID-19) pandemic.

Download PDF

 

Share the Post:

Related Posts

News & Information

Slice of Pie – Volume 23, Issue 1, 2023

“A Slice of Pie” is an ongoing publication keeping our readers informed about important public policy issues. It is the mission of the Policy Information …

Read More →
TPA_ODP

2023 Lifesharing Conference – October 23 and 24 – Eden Resort Lancaster

Pennsylvania’s Lifesharing Coalition Presents The 11th Annual Lifesharing Conference October 23 and October 24, 2023 Eden Resort Lancaster Click here for more information or visit our …

Read More →
News & Information

CFHS Issues 2022 Impact Report

The Center for Healthcare Solutions (CFHS) is pleased to issue its 2022 Impact Report, a sweeping review of the essential programs for members, and a …

Read More →